TYK Medicines, Inc.
- Biotech or pharma, therapeutic R&D
TYK Medicines (2410.HK) is a biotech focused on innovative anti-cancer drugs, including EGFR TKI, ROS1/NTRK, RET, exon20ins, CDK2, CDK2/4, CDK7, CDK2/4, CDK4, YAP/TEAD, EGFR PROTAC, and PI3Kα allosteric inhibitor.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}